Last reviewed · How we verify

NCT04146844

Prevalence of Two Major Geriatric Syndromes: Sarcopenia and Frailty

Completed Last updated 10 May 2021
What this trial tests

trial in Sarcopenia in 500 participants. Completed in 25 April 2021.

Timeline
15 December 2020
Primary endpoint
1 April 2021
25 April 2021

Quick facts

Lead sponsorGoztepe Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment500
Start date15 December 2020
Primary completion1 April 2021
Estimated completion25 April 2021
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Goztepe Training and Research Hospital

Who can join

65 and older, any sex, with Sarcopenia or Frailty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sarcopenia and frailty are two major syndromes in older adults. They are shown to be associated with low levels of functioning and higher rates of morbidity and mortality. In this study, we aim to report the prevalence of sarcopenia and frailty by using simple assessment methods such as SARC-F and FRAIL, respectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Goztepe Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04146844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing